 |
市場調査レポート
商品コード
1441177
MRIガイド下神経外科アブレーションの世界市場規模、シェア、成長分析、製品別、最終用途別 - 産業予測2023～2030年Global MRI-Guided Neurosurgical Ablation Market Size, Share, Growth Analysis, By Product(MRI Guided RF Ablation Systems, MRI Guided Laser Ablation Systems), By End-use(Hospitals, Clinics and Ambulatory Surgical Centers) - Industry Forecast 2023-2030 |
||||||
| MRIガイド下神経外科アブレーションの世界市場規模、シェア、成長分析、製品別、最終用途別 - 産業予測2023～2030年 |
|
出版日: 2024年02月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のMRIガイド下神経外科アブレーションの市場規模は、2022年に6億831万米ドルと評価され、2023年の6億5,271万米ドルから、2031年までには11億4,688万米ドルに成長し、予測期間（2024～2031年）のCAGRは7.3％で成長する見通しです。
世界のMRIガイド下神経外科アブレーション市場は、より広範な医療技術展望の中で重要なセグメントを占めており、神経疾患の精密かつ低侵襲な治療のための革新的なソリューションを提供しています。この市場には、磁気共鳴画像（MRI）を利用して脳内の外科的アブレーション手技を誘導するように設計されたさまざまな先進技術や装置が含まれます。これらの手技は主に、脳腫瘍、てんかん、パーキンソン病など、標的組織の切除を必要とする神経疾患の治療を目的としています。ビジネスの観点からは、MRIガイド下脳神経外科アブレーション市場は、医療機器やヘルスケア分野で事業を展開する企業にとって大きなビジネスチャンスとなります。世界的に神経疾患の有病率が増加し、低侵襲な治療オプションに対する需要が高まる中、手技のリスクや回復時間を低減しながら患者の転帰を改善できる高度な技術に対するニーズが高まっています。その結果、MRIガイド下神経外科アブレーション・システムのメーカーや開発者は、その製品やサービスに対する需要の急増を目の当たりにしています。市場成長を促進する主な要因の1つは、神経外科手術の精度、正確性、安全性を高める最先端技術の絶え間ない革新と開発です。研究開発に投資する企業は、高度な画像処理機能、ロボット支援、リアルタイムモニタリング機能を備えた次世代MRIガイド下アブレーションシステムを導入しています。こうした技術的進歩は、ヘルスケア専門家が複雑な手技をより高い信頼性と効率で実施できるようにするだけでなく、患者の転帰と満足度の向上にも貢献しています。
さらに、入院期間の短縮、術後合併症の減少、患者の回復時間の短縮といった要因によって、脳神経外科手術における低侵襲技術の採用が増加しており、この市場はその恩恵を受けています。MRIガイド下アブレーションは、周囲の健常構造物へのダメージを最小限に抑えつつ、病変組織を正確に狙い撃ちできるため、従来の外科的アプローチと比較して明確な利点があります。このため、侵襲性の低い治療法へのシフトが進み、MRIガイド下神経外科アブレーション・システムの需要が高まっています。技術革新や治療パラダイムの転換に加え、市場成長はヘルスケア支出の増加、神経疾患に対する意識の高まり、特に新興国における患者数の拡大といった要因にも影響されています。しかし、初期コストの高さ、償還の問題、規制上の制約といった課題が市場拡大の障害となる可能性があるため、業界各社はこれらの障壁に効果的に対処するための戦略的な取り組みが必要です。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界のMRIガイド下神経外科アブレーション市場：製品別
- 市場概要
- MRIガイド付きRFアブレーションシステム
- MRI誘導レーザーアブレーションシステム
- MRIガイド付き集束超音波システムおよびアクセサリ
世界のMRIガイド下神経外科アブレーション市場：最終用途別
- 市場概要
- 病院
- クリニックと外来手術センター
世界のMRIガイド下神経外科アブレーション市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 主要5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic
- InSightec Ltd.
- Elekta AB
- Monteris Medical
- Profound Medical
- Boston Scientific Corporation
- MR Solutions
- MRI Interventions, Inc.
- Varian Medical Systems
- AngioDynamics
- Abbott Laboratories
- Hitachi Medical Systems
- Siemens Healthineers
- IMRIS, Deerfield Imaging
- Accuray Incorporated
- Perseon Corporation
- Elekta AB
- Isacord
- Monteris Medical
- Focal Therapeutics
- Shamrad Electronics
Global MRI-Guided Neurosurgical Ablation Market size was valued at USD 608.31 million in 2022 and is poised to grow from USD 652.71 million in 2023 to USD 1146.88 million by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).
The global MRI-guided neurosurgical ablation market represents a crucial segment within the broader medical technology landscape, offering innovative solutions for precise and minimally invasive treatment of neurological disorders. This market encompasses a range of advanced technologies and devices designed to utilize magnetic resonance imaging (MRI) for guiding surgical ablation procedures in the brain. These procedures are primarily aimed at treating conditions such as brain tumors, epilepsy, Parkinson's disease, and other neurological disorders that may require targeted tissue ablation. From a business perspective, the MRI-guided neurosurgical ablation market presents significant opportunities for companies operating in the medical device and healthcare sectors. With the increasing prevalence of neurological disorders globally and growing demand for minimally invasive treatment options, there is a rising need for advanced technologies that can improve patient outcomes while reducing procedural risks and recovery times. As a result, manufacturers and developers of MRI-guided neurosurgical ablation systems are witnessing a surge in demand for their products and services. One of the key drivers propelling market growth is the continuous innovation and development of cutting-edge technologies that enhance the precision, accuracy, and safety of neurosurgical procedures. Companies investing in research and development are introducing next-generation MRI-guided ablation systems equipped with advanced imaging capabilities, robotic assistance, and real-time monitoring features. These technological advancements not only empower healthcare professionals to perform complex procedures with greater confidence and efficiency but also contribute to better patient outcomes and satisfaction.
Moreover, the market is benefiting from the growing adoption of minimally invasive techniques in neurosurgery, driven by factors such as shorter hospital stays, reduced post-operative complications, and faster recovery times for patients. MRI-guided ablation offers distinct advantages over traditional surgical approaches by enabling precise targeting of diseased tissue while minimizing damage to surrounding healthy structures. This has led to a shift towards less invasive treatment modalities, thereby fueling the demand for MRI-guided neurosurgical ablation systems. In addition to technological innovation and shifting treatment paradigms, market growth is also influenced by factors such as increasing healthcare expenditure, rising awareness about neurological disorders, and expanding patient populations, particularly in emerging economies. However, challenges such as high initial costs, reimbursement issues, and regulatory constraints may pose obstacles to market expansion, necessitating strategic initiatives by industry players to address these barriers effectively.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global MRI-Guided Neurosurgical Ablation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global MRI-Guided Neurosurgical Ablation Market Segmental Analysis
Global MRI-guided neurosurgical ablation market is segmented on the basis of technology, end use and region. By Technology, the market is segmented into MRI guided RF ablation systems, MRI guided laser ablation systems, MRI guided focused ultrasound systems and accessories. By end use, the market is segmented into Hospitals, Clinics and Ambulatory surgical centers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global MRI-Guided Neurosurgical Ablation Market
The global MRI-guided neurosurgical ablation market has experienced significant growth in recent years, driven by several factors including technological advancements, increasing prevalence of neurological disorders, and rising demand for minimally invasive surgical procedures. One key market driver is the growing adoption of MRI-guided neurosurgical ablation techniques due to their ability to provide real-time imaging, precise targeting, and enhanced safety compared to traditional surgical methods. MRI-guided procedures allow surgeons to visualize the target tissue and surrounding structures with high resolution, enabling accurate placement of the ablation probe and minimizing damage to healthy brain tissue. This has led to improved patient outcomes, reduced complications, and shorter recovery times, driving the demand for MRI-guided neurosurgical ablation systems globally.
Restraints in the Global MRI-Guided Neurosurgical Ablation Market
However, despite the numerous advantages, the market also faces certain restraints that could hinder its growth trajectory. One notable restraint is the high cost associated with MRI-guided neurosurgical ablation procedures and equipment. The initial capital investment required for setting up MRI-guided surgical suites and purchasing specialized equipment can be substantial, limiting accessibility for healthcare facilities, particularly in emerging economies with constrained healthcare budgets. Moreover, reimbursement challenges and regulatory hurdles may further impede market expansion, particularly in regions where healthcare reimbursement policies are stringent or uncertain. Addressing these cost-related barriers and enhancing reimbursement frameworks will be crucial for broader adoption of MRI-guided neurosurgical ablation technologies worldwide.
Market Trends of the Global MRI-Guided Neurosurgical Ablation Market
In terms of trends, one prominent development in the MRI-guided neurosurgical ablation market is the ongoing innovation and development of advanced ablation techniques and platforms. Manufacturers are increasingly focusing on improving the precision, efficiency, and safety of neurosurgical ablation procedures through technological innovations such as real-time temperature monitoring, automated planning software, and integrated navigation systems. Additionally, there is a growing trend towards the integration of MRI-guided ablation systems with other imaging modalities, such as positron emission tomography (PET) or computed tomography (CT), to enhance the accuracy of targeting and treatment planning. These advancements are expected to drive further adoption of MRI-guided neurosurgical ablation techniques and expand their applications in treating various neurological conditions, including brain tumors, epilepsy, and movement disorders, thus fueling market growth in the coming years.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global MRI-Guided Neurosurgical Ablation Market by Product
- Market Overview
- MRI Guided RF Ablation Systems
- MRI Guided Laser Ablation Systems
- MRI Guided Focused Ultrasound Systems and Accessories
Global MRI-Guided Neurosurgical Ablation Market by End-use
- Market Overview
- Hospitals
- Clinics and Ambulatory Surgical Centers
Global MRI-Guided Neurosurgical Ablation Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- InSightec Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elekta AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Monteris Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Profound Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MR Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MRI Interventions, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Varian Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AngioDynamics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IMRIS, Deerfield Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Accuray Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perseon Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elekta AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Isacord
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Monteris Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Focal Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shamrad Electronics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
